The progressive deposition of misfolded hyperphosphorylated tau is a pathological hallmark and it correlates with the disease progression of tauopathies, such as Alzheimer's disease. My research focuses on employing cellular biology and biochemical methods to elucidate the molecular mechanisms governing the generation of fibrilar tau strains. The characterisation of these biological phenomena will help us understand better the cellular pathways underlying the toxicitiy in tauopathies, where early diagnosis is limited and current therapeutics entirely absent.
